Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity Management
Kevin Lin, Ateev Mehrotra, Thomas C. Tsai
Abstract
This cross-sectional study investigates rates of bariatric surgery and glucagon-like peptide-1 receptor agonist prescription among adults without diabetes in 2022 to 2023.
Topics & Concepts
ObesityMedicineGlucagon-like peptide 1 receptorGlucagon-like peptide-1AgonistMedical prescriptionReceptorDiabetes mellitusInternal medicineWeight managementEndocrinologySurgeryPharmacologyType 2 diabetesWeight lossBariatric Surgery and OutcomesPharmacology and Obesity TreatmentDiabetes Treatment and Management